Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Affibody AB

www.affibody.com

Latest From Affibody AB

Deal Watch: Celgene Joins Line Of Partners Tapping Exscientia’s AI-Driven Discovery Engine

While the proposed Bristol/Celgene merger nears an April vote, Celgene continues a recent spate of deal-making, paying $25m up front to Exscientia to discover small molecule candidates for cancer and autoimmune disease.

Business Strategies Commercial

Scandinavia Serves Up Two Partners For Alexion, In Its Rare Disease Sweet-Spot

Leading US biotech Alexion is to collaborate with two European biotechs, Affibody and Zealand, on early-stage products for rare diseases, involving bivalent antibody-mimetic scaffolds and novel peptides.

 

Deals Blood & Coagulation Disorders

Alexion Continues Pipeline Rebuilding With $400m Takeout Of Syntimmune

Alexion’s third deal this year brings privately held Syntimmune and its Phase Ib/IIa candidate for three IgG-mediated rare disorders, including warm autoimmune hemolytic anemia, for a $400m upfront price tag.

Deals Rare Diseases

Affibody CEO On Recently Launched Psoriasis Trial

David Bejker, CEO of Affibody, a Swedish biotech developing a novel psoriasis product, talks to Scrip's Lucie Ellis about the company's recently launched Phase II trial.

StartUps and SMEs Research and Development Strategies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • Affibody AB
  • Senior Management
  • David Bejker, CEO
    Johan Stuart, CFO
    Fredrik Frejd, PhD, CSO
  • Contact Info
  • Affibody AB
    Phone: (46) 8 59 88 38 00
    Gunnar Asplunds Allé 24
    Solna, SE-171 63
    Sweden
Advertisement
Advertisement
UsernamePublicRestriction

Register